Reading MLSS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MLSS free→Reading MLSS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MLSS free→QuarterlyIQ Insights · MLSS
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Changes in Registrant’s Certifying Accountant On April 30, 2026, the Board of Directors of Milestone Scientific Inc. (the “Company”) approved the dismissal of CBIZ CPAs P.C. (“CBIZ CPAs”) as the independent registered public accounting firm to the Company effective as of May 15, 2026. The Company engaged Grassi & Co., CPAs, P.C. to be the independent registered public accounting firm to the Company for the fiscal year ending December 31, 2026. The approval of the dismissal of CBIZ CPAs was ap…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 30, 2026 (the “Effective Date”), the Compensation Committee of the Board of Directors (the “Compensation Committee”) of Milestone Scientific Inc. (the “Company”) approved a one-time stock option exchange program (the “Exchange Program”) for outstanding stock options granted under the Company’s Amended and Restated 2020 Equity Incentive Pla…
Unregistered Sales of Equity Securities The disclosures set forth in
Entry into a Material Definitive Agreement On April 20, 2026, Milestone Scientific Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of an aggregate of 7,962,963 units (the “Units”), with each Unit consisting of (i) one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) one warrant to purchase one share…
Entry into a Material Definitive Agreement On March 31, 2026, Milestone Scientific Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Amended and Restated Memorandum of Understanding, dated January 13, 2026 (the “MOU”), with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”). According to BP4, it was then the owner of 11.31% of the outstanding shares of common stock o…
Entry into a Material Agreement On January 15, 2026, Milestone Scientific Inc. (“the Company”) entered into an Amended and Restated Memorandum of Understanding (the “MOU”) with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”). According to BP4, it was then the owner of 11.31% of the outstanding shares of common stock of the Company. BP4 agreed, among other things, subject to certain con…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On November 7, 2025, Mr. Leonard A. Osser, a director of Milestone Scientific Inc., resigned as a director of the company, effective immediately. Mr. Osser wrote that it was an appropriate time to relinquish his director position. Mr. Osser, however, will continue to be involved with the company through his employment agreement and through the consu…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On October 8, 2025, Milestone Scientific Inc. (“the Company”) received a letter from NYSE American LLC (“NYSE American” or the “Exchange”) stating that the Company is not in compliance with the continued listing standards as outlined in Section(s) 1003(a)(ii), and (iii) of the NYSE American Company Guide (the “Company Guide”). To maintain its listing, the Company must submit a plan of complianc…
Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers Effective July 31, 2025, the Board of Directors of Milestone Scientific Inc. (the “ Company ”) appointed Eric Hines as President and Chief Executive Officer, and as a director of the Company. From July 31, 2025 through December 31, 2025 (the “ Initial Term ”), Mr. Hines will be entitled to base compensation at the rate of $15,000 per month. From Jan…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company. Mr. Thiyagalingam is currently the Chief Executive Officer of PainTEQ, a manufacturer of proprietary medical equipment. Prior to being named PainTEQ’…
Changes in Registrant ’ s Certifying Accountant Based on information provided by Marcum LLP ("Marcum"), the independent registered public accounting firm of Milestone Scientific Inc. (the "Company"), CBIZ CPAs P.C. ("CBIZ CPAs") acquired the attest business of Marcum, effective November 1, 2024. Marcum continued to serve as the Company's independent registered public accounting firm through April 22, 2025. On April 22, 2025, Marcum resigned as the Company's independent registered public accou…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.